FDA NDC Directory · JSON-LD · Markdown

PAVBLU

NDC 55513-065 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameaflibercept-ayyh
Labeler / ManufacturerAmgen, Inc
Marketing categoryBiologic License Application · App BLA761298
Dosage form / routeINJECTION, SOLUTION · INTRAVITREAL
Active ingredientsAFLIBERCEPT (2 mg/.05mL)
Marketing started20241028
Package count2

External sources

Source: openFDA. Public-domain (CC0).